From a genetic perspective, the authors of study [66] evidenced a correlation between specific immune cell signatures, including CD20%-positive lymphocytes, CD62L-positive monocytes, and CD33br HLA DR+ CD14-cells, and an elevated risk of osteonecrosis. This evidence concerns the gene SELL and osteonecrosis.